Ticker

No recent analyst price targets found for CNVCF.

Latest News for CNVCF

BioHarvest appoints former Israeli health chief Hezi Levy to board

BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Thursday that it has appointed former Israeli health ministry chief Hezi Levy to the board effective immediately. David Tsur will step down from its board of directors after more than four years of service, the company said in a statement.

Proactive Investors • Mar 5, 2026
BioHarvest Sciences CEO reflects on milestone year in shareholder letter

BioHarvest Sciences Inc (NASDAQ:BHST) said its first full year as a Nasdaq-listed company was marked by revenue growth, expanding operations, and balance sheet improvements, according to a shareholder letter released on Wednesday by CEO Ilan Sobel. In the letter, Sobel outlined operating and financial progress made in 2025 and described the company's position entering 2026.

Proactive Investors • Jan 7, 2026
BioHarvest gets $1.6M Israeli grant to advance botanical synthesis technology

BioHarvest Sciences Inc (NASDAQ:BHST) said on Thursday it has been awarded a $1.6 million grant from the Israeli Innovation Authority (IIA) to support the development of its second-generation Botanical Synthesis manufacturing process. The biotechnology company said the funding was approved under the IIA's Bio-Convergence program, which backs technologies combining biology, engineering, data science and artificial…

Proactive Investors • Dec 18, 2025

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for CNVCF.

No Senate trades found for CNVCF.

No House trades found for CNVCF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top